Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies

por Raghunandan, Sharmila, Qayed, Muna, Watkins, Ben K., Graiser, Michael, Gorfinkel, Lev, Westbrook, Adrianna, Gillespie, Scott, Bratrude, Brandi, Petrovic, Aleksandra, Suessmuth, Yvonne, Horan, John, Kean, Leslie S., Langston, Amelia A.
Publicado 2023

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysi...

por Raghunandan, Sharmila, Gorfinkel, Lev, Bratrude, Brandi, Suessmuth, Yvonne, Hebert, Kyle, Neuberg, Donna, Williams, Kirsten M., Schoettler, Michelle L., Langston, Amelia A., Kean, Leslie S., Qayed, Muna, Horan, John, Watkins, Benjamin K.
Publicado 2023

Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis

por Raghunandan, Sharmila, Gorfinkel, Lev, Graiser, Michael, Bratrude, Brandi, Suessmuth, Yvonne, Gillespie, Scott, Westbrook, Adrianna Lynn, Williams, Kirsten M., Schoettler, Michelle L., Kean, Leslie S., Horan, John, Langston, Amelia A., Qayed, Muna, Watkins, Benjamin
Publicado 2023

Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease

por Wobma, Holly, Kapadia, Malika, Kim, Haesook T., Alvarez-Calderon, Francesca, Baumeister, Susanne H. C., Duncan, Christine, Forrest, Suzanne, Gorfinkel, Lev, Huang, Jennifer, Lehmann, Leslie E., Li, Hojun, Schwartz, Marc, Koreth, John, Ritz, Jerome, Kean, Leslie S., Whangbo, Jennifer S.
Publicado 2023